| Management target | Revenue 10.0% FY27 |
|---|
| Revenue growth | 9.48% YoY in Q1 FY27. |
|---|---|
| Margins | Higher raw/packing material costs; price hikes taken to offset. |
| Demand visibility | Strong in Women's Hygiene; soft in Pain Management rubs. |
| Management confidence | High for double-digit annual growth. |
Growth
Net Sales grew to 102.97 Cr from 94.05 Cr. PAT fell to 4.37 Cr from 8.31 Cr due to exceptional items.
Outlook
Targeting double-digit revenue and profit growth for FY27. Projecting 15 Cr from razors and 10 Cr from Plastry.
Risks
Pain management volume de-growth (-3.4%), West Asia war impacting COGS, and new FSSAI restrictions on electrolyte drinks.
Investor Presentation filed with NSE, NSE: AMRUTANJAN. Summary written with AI assistance from the document.
Amrutanjan Health Care Ltd: key numbers
- Share price
- ₹521.55
- Market cap
- ₹1,508 Cr
- Revenue (annual)
- ₹502.6 Cr
- Net profit (annual)
- ₹57.92 Cr
- P/E (TTM)
- 27.9×Sector 47.3×
- Promoter holding
- 46.52%+0.00% QoQ
- FII holding
- 2.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amrutanjan Health Care Ltd
All →Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend of Rs. 2.90 per share.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend.
- Value
- ₹0.06 Cr
Amrutanjan Health Care Business Update
Amrutanjan Health Care Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26. This disclosure forms part of the company's Annual Report requirements.
Amrutanjan Health Care Annual Report
Amrutanjan Health Care Limited submitted its 89th Annual Report for the financial year 2025-26. The company scheduled its Annual General Meeting for September 23, 2026.
Amrutanjan Health Care Dividend
Amrutanjan Health Care Limited has fixed September 11, 2026, as the record date for the payment of the final dividend for the financial year 2025-26.